SK Bioscience
A biotechnology company focused on vaccine research, development, and large-scale vaccine manufacturing. The organization conducts vaccine R&D across multiple indications, operates advanced vaccine production facilities, pursues global partnerships and commercialization, and publishes investor and ESG disclosures.
Industries
biopharma
biotechnology
pharmaceutical
Nr. of Employees
Very Large (1000+)
SK Bioscience
Products
Cell-culture quadrivalent influenza vaccine (developed)
A quadrivalent seasonal influenza vaccine produced using cell-culture manufacturing.
Cell-culture trivalent influenza vaccine (developed)
A trivalent seasonal influenza vaccine produced using cell-culture manufacturing.
Herpes zoster (shingles) vaccine (developed)
A vaccine developed for prevention of herpes zoster.
Varicella (chickenpox) vaccine (developed)
A vaccine developed for prevention of varicella (chickenpox).
Protein-conjugate typhoid vaccine (for export)
A protein-conjugate typhoid vaccine developed for export markets.
COVID-19 vaccine (domestically developed)
A domestically developed vaccine for SARS-CoV-2.
Cell-culture quadrivalent influenza vaccine (developed)
A quadrivalent seasonal influenza vaccine produced using cell-culture manufacturing.
Cell-culture trivalent influenza vaccine (developed)
A trivalent seasonal influenza vaccine produced using cell-culture manufacturing.
Herpes zoster (shingles) vaccine (developed)
A vaccine developed for prevention of herpes zoster.
Varicella (chickenpox) vaccine (developed)
A vaccine developed for prevention of varicella (chickenpox).
Protein-conjugate typhoid vaccine (for export)
A protein-conjugate typhoid vaccine developed for export markets.
COVID-19 vaccine (domestically developed)
A domestically developed vaccine for SARS-CoV-2.
Expertise Areas
- Vaccine research and development
- Biologics and vaccine manufacturing
- Clinical development and trial operations
- Regulatory submissions and interactions (CTA/IND)
Key Technologies
- Cell-culture vaccine production
- Protein-conjugate vaccine platform
- Large-scale biologics manufacturing
- Vaccine formulation and adjuvant technologies